Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy

Although most differentiated thyroid cancers show excellent prognosis, treating radioiodine refractory differentiated thyroid cancer (RR-DTC) is challenging. Various therapies, including chemotherapy, radiotherapy, and targeted therapy, have been applied for RR-DTC but show limited effectiveness. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chae Moon, Ahn, Byeong-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649198/
https://www.ncbi.nlm.nih.gov/pubmed/29085335
http://dx.doi.org/10.3389/fendo.2017.00260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649198/
https://www.ncbi.nlm.nih.gov/pubmed/29085335
http://dx.doi.org/10.3389/fendo.2017.00260

Ejemplares similares